[HTML][HTML] Epidemiology, Treatment Trends, and Outcomes of Multiple Myeloma in the Middle East and Africa: A Systematic Review
M Mattar, A Bazarbachi, O Abduljalil… - Clinical Hematology …, 2024 - ncbi.nlm.nih.gov
Background Globally, multiple myeloma (MM) ranks 24 th among the most common cancers.
The Middle East and Africa are affected by an increasing trend in MM incidence, owing to …
The Middle East and Africa are affected by an increasing trend in MM incidence, owing to …
Cancer testis antigen MAGE C1 can be used to monitor levels of circulating malignant stem cells in the peripheral blood of multiple myeloma patients
Purpose Monitoring the levels of malignant disease-causing cells in multiple myeloma, as
opposed to the clinical symptoms alone, is an important move forward in the management of …
opposed to the clinical symptoms alone, is an important move forward in the management of …
Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell …
C Blimark, L Veskovski, J Westin… - European Journal of …, 2011 - Wiley Online Library
Introduction: Today, a number of therapeutic options are available as the patient with
myeloma relapses from initial treatment with high‐dose melphalan and autologous stem cell …
myeloma relapses from initial treatment with high‐dose melphalan and autologous stem cell …
Progress And Challenges In Africa At The Time Of Molecular Haematology
L Luzzatto - Nigerian Journal of Haematology, 2023 - njhaem.org.ng
The study of blood diseases has been traditionally at the border between clinical medicine
and laboratory science. Many of us have been attracted to haematology by this combination …
and laboratory science. Many of us have been attracted to haematology by this combination …
Autologous stem cell transplantation in the management of multiple myeloma
MA Gertz, CB Reeder - Multiple Myeloma: Diagnosis and Treatment, 2013 - Springer
Autologous stem cell transplantation has been shown to improve the survival in patients with
multiple myeloma. Seven randomized clinical trials have been reported demonstrating the …
multiple myeloma. Seven randomized clinical trials have been reported demonstrating the …
Analýza bialelických delecí u pacientů s mnohočetným myelomem pomocí array CGH
J Fröhlich - 2012 - is.muni.cz
Anotace Bialelické nebo též homozygotní delece lze jednoduše definovat jako ztrátu obou
alel jednoho genu v genomu buňky. Tyto genetické změny hrají významnou roli při …
alel jednoho genu v genomu buňky. Tyto genetické změny hrají významnou roli při …
[图书][B] Clinical and Population-based Studies in Multiple Myeloma and Monoclonal Gammopathy–Focus on Infections
CH Blimark - 2014 - gupea.ub.gu.se
Multiple myeloma is a haematological disorder of the bone marrow. It is preceded by the
benign precursor monoclonal gammopathy of undetermined significance (MGUS). In …
benign precursor monoclonal gammopathy of undetermined significance (MGUS). In …
[引用][C] Covalent Modifications of Melphalan Potentiate its Anticancer Effects. 1: 545 doi: 10.4172/scientificreports. 545 Page 2 of 3 Volume 1• Issue 12• 2012 drugs can …
K Jani, K Bashear, A Husicic, J Garner, K Nugent - … been selected and modified in a …, 2007